Search Results - "LILLEBY, K"

A prospective, randomized study of cryotherapy during administration of high-dose melphalan to decrease the severity and duration of oral mucositis in patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation by LILLEBY, K, GARCIA, P, GOOLEY, T, MCDONNNELL, P, TABER, R, HOLMBERG, L, MALONEY, D. G, PRESS, O. W, BENSINGER, W

“…Forty patients with multiple myeloma scheduled to receive melphalan 200 mg/m(2) followed by autologous stem cell transplantation were randomly assigned to…”
Get full text

Three to six year follow-up of normal donors who received recombinant human granulocyte colony-stimulating factor by CAVALLARO, A. M, LILLEBY, K, MAJOLINO, I, STORB, R, APPELBAUM, F. R, ROWLEY, S. D, BENSINGER, W. I

“…One hundred and one donors who had received filgrastim (rhG-CSF) for the purpose of donating either granulocytes or peripheral blood stem cells (PBSC) for…”
Get full text

Factors that influence collection and engraftment of autologous peripheral-blood stem cells by Bensinger, W, Appelbaum, F, Rowley, S, Storb, R, Sanders, J, Lilleby, K, Gooley, T, Demirer, T, Schiffman, K, Weaver, C

“…To analyze factors that affect the collection of peripheral-blood stem cells (PBSC) before transplant and the tempo of engraftment after transplant. A…”
Get more information

Autologous transplantation with peripheral blood mononuclear cells collected after administration of recombinant granulocyte stimulating factor by BENSINGER, W, SINGER, J, STORB, R, WEAVER, C, WEIDEN, P, BUCKNER, C. D, APPELBAUM, F, LILLEBY, K, LONGIN, K, ROWLEY, S, CLARKE, E, CLIFT, R, HANSEN, J, SHIELDS, T

“…Peripheral blood mononuclear cells (PBMC) were collected after the administration of recombinant human granulocyte colony-stimulating factor (rhG-CSF) and used…”
Get full text

Peripheral blood stem cells (PBSCs) collected after recombinant granulocyte colony stimulating factor (rhG-CSF): an analysis of factors correlating with the tempo of engraftment after transplantation by Bensinger, W I, Longin, K, Appelbaum, F, Rowley, S, Weaver, C, Lilleby, K, Gooley, T, Lynch, M, Higano, T, Klarnet, J

“…Factors affecting mobilization and engraftment were analysed in 54 patients undergoing transplant using autologous PBSCs mobilized with high-dose recombinant…”
Get more information

Treatment of cytomegalovirus pneumonia with ganciclovir and intravenous cytomegalovirus immunoglobulin in patients with bone marrow transplants by Reed, E C, Bowden, R A, Dandliker, P S, Lilleby, K E, Meyers, J D

“…To determine if the combination of ganciclovir and intravenous cytomegalovirus immunoglobulin is effective in patients with cytomegalovirus pneumonia after…”
Get more information

High-dose therapy followed by autologous hematopoietic stem-cell infusion for patients with multiple myeloma by Bensinger, W I, Rowley, S D, Demirer, T, Lilleby, K, Schiffman, K, Clift, R A, Appelbaum, F R, Fefer, A, Barnett, T, Storb, R, Chauncey, T, Maziarz, R T, Klarnet, J, McSweeney, P, Holmberg, L, Maloney, D G, Weaver, C H, Buckner, C D

“…To evaluate the outcome of patients with multiple myeloma (MM) who received high-dose therapy followed by autologous bone marrow (BM) or peripheral-blood…”
Get more information

The Effects of Daily Recombinant Human Granulocyte Colony-Stimulating Factor Administration on Normal Granulocyte Donors Undergoing Leukapheresis by Bensinger, William I., Price, Thomas H., Dale, David C., Appelbaum, Frederick R., Clift, Reginald, Lilleby, Kathy, Williams, Barbara, Storb, Rainer, Thomas, E. Donnall, Buckner, C. Dean

“…The effects of daily administration of recombinant human granulocyte colony-stimulating factor (rhG-CSF) to eight normal volunteers donating granulocytes for…”
Get full text

Clinical outcome of breast and ovarian cancer patients treated with high-dose chemotherapy, autologous stem cell rescue and THERATOPE® STn-KLH cancer vaccine by HOLMBERG, L. A, OPARIN, D. V, GOOLEY, T, LILLEBY, K, BENSINGER, W, REDDISH, M. A, MACLEAN, G. D, LONGENECKER, B. M, SANDMAIER, B. M

“…The purpose of this study was to evaluate the toxicity and potential efficacy of administering the THERATOPE STn-KLH cancer vaccine to ovarian and breast…”
Get full text

Syngeneic Transplantation With Peripheral Blood Mononuclear Cells Collected After the Administration of Recombinant Human Granulocyte Colony-Stimulating Factor by Weaver, C.H., Buckner, CD, Longin, K., Appelbaum, F.R., Rowley, S., Lilleby, K., Miser, J., Storb, R., Hansen, J.A., Bensinger, W.

“…Five syngeneic transplants were performed in four patients following myeloablative therapy using unmodified peripheral blood mononuclear cells (PBMCs)…”
Get full text

Factors influencing collection of peripheral blood stem cells in patients with multiple myeloma by Demirer, T, Buckner, C D, Gooley, T, Appelbaum, F R, Rowley, S, Chauncey, T, Lilleby, K, Storb, R, Bensinger, W I

“…This study was performed to determine the factors influencing the collection of autologous peripheral blood stem cells (PBSC) in patients with multiple myeloma…”
Get more information

Effect of different chemotherapy regimens on peripheral-blood stem-cell collections in patients with breast cancer receiving granulocyte colony-stimulating factor by Demirer, T, Buckner, C D, Storer, B, Lilleby, K, Rowley, S, Clift, R, Appelbaum, F R, Storb, R, Bensinger, W I

“…To evaluate the effects of chemotherapy regimens on peripheral-blood stem-cell (PBSC) yields in patients with breast cancer who receive granulocyte…”
Get more information

Phase I-II Trial of Foscarnet for Prevention of Cytomegalovirus Infection in Autologous and Allogeneic Marrow Transplant Recipients by Reusser, Pierre, Gambertoglio, John G., Lilleby, Kathy, Meyers, Joel D.

“…The safety and efficacy of foscarnet for prevention of cytomegalovirus (CMV) infection was evaluated in 19 CMV-seropositive bone marrow transplant (BMT)…”
Get full text

Peripheral-blood stem-cell collections after paclitaxel, cyclophosphamide, and recombinant human granulocyte colony-stimulating factor in patients with breast and ovarian cancer by Demirer, T, Rowley, S, Buckner, C D, Appelbaum, F R, Lilleby, K, Storb, R, Schiffman, K, Bensinger, W I

“…Here we evaluate Taxol (paclitaxel; Bristol-Myers Squibb, Princeton, NJ) and cyclophosphamide (CY) with recombinant human granulocyte colony-stimulating factor…”
Get more information

Syngeneic marrow transplantation in patients with multiple myeloma by Bensinger, W I, Demirer, T, Buckner, C D, Appelbaum, F R, Storb, R, Lilleby, K, Weiden, P, Bluming, A Z, Fefer, A

“…Eleven patients with advanced multiple myeloma (MM) received syngeneic marrow (n = 10) or peripheral blood stem cell (n = 1) transplants following…”
Get more information

Autologous transplantation with peripheral blood stem cells collected after granulocyte colony-stimulating factor in patients with acute myelogenous leukemia by Demirer, T, Petersen, F B, Bensinger, W I, Appelbaum, F R, Fefer, A, Rowley, S, Sanders, J, Chauncey, T, Storb, R, Lilleby, K, Buckner, C D

“…The use of peripheral blood stem cells (PBSC) with or without bone marrow (BM) in patients with acute myelogenous leukemia (AML) undergoing autologous…”
Get more information

Phase II study of high-dose busulfan, melphalan and thiotepa with autologous peripheral blood stem cell support in patients with malignant disease by Schiffman, K S, Bensinger, W I, Appelbaum, F R, Rowley, S, Lilleby, K, Clift, R A, Weaver, C H, Demirer, T, Sanders, J E, Petersdorf, S, Gooley, T, Weiden, P, Zuckerman, N, Montgomery, P, Maziarz, R, Klarnet, J P, Rivkin, S, Trueblood, K, Storb, R, Holmberg, L, Buckner, C D

“…The purpose of this study was to determine the toxicities and potential effectiveness of high-dose busulfan, melphalan and thiotepa (Bu/Mel/TT) followed by…”
Get more information

High-dose busulfan and cyclophosphamide followed by autologous transplantation in patients with advanced breast cancer by Demirer, T, Buckner, C D, Appelbaum, F R, Clift, R, Storb, R, Myerson, D, Lilleby, K, Rowley, S, Bensinger, W I

“…This study was conducted to evaluate the efficacy of high-dose busulfan (BU) and cyclophosphamide (CY) in patients undergoing autologous hematopoietic stem…”
Get more information

Pilot trial of cytoprotection with amifostine given with high-dose chemotherapy and autologous peripheral blood stem cell transplantation by CHAUNCEY, T. R, GOOLEY, T. A, LLOID, M. E, SCHUBERT, M. M, LILLEBY, K, HOLMBERG, L, BENSINGER, W. I

“…In an attempt to limit toxicities associated with dose-intensive therapy used for transplant regimens, we performed a pilot study using amifostine with…”
Get full text

Influence of total nucleated cell dose from marrow harvests on outcome in patients with acute myelogenous leukemia undergoing autologous transplantation by Demirer, T, Gooley, T, Buckner, C D, Petersen, F B, Lilleby, K, Rowley, S, Sanders, J, Storb, R, Appelbaum, F R, Bensinger, W I

“…This retrospective study was conducted to determine whether the total number of nucleated cells (TNC)/kg collected at marrow harvest was associated with…”
Get more information